NVCT

Nuvectis Pharma, Inc.

Pharmaceutical PreparationsNasdaq<br>Emerging growth company

Total Trades

86

Buys

84

Sells

1

Largest Trade

N/A

Insiders

8

Institutional Funds

39

Inst. Value

$1M+

Activist Filings

11

Insider Trades

InsiderTitleTypeValueSharesPriceDate
BENTSUR RONChairman & CEOBUY$15K–$50K2K$10.86Mar 16, 2023
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K500$7.65Dec 22, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K150$7.45Nov 30, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K450$7.41Nov 29, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K750$7.23Nov 21, 2022
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K300$7.15Nov 18, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K1K$7.07Nov 16, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K1K$7.34Oct 3, 2022
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K220$7.87Sep 27, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K2K$7.85Sep 27, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K2K$8.29Sep 6, 2022
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K404$8.31Sep 6, 2022
Shemesh ShayChief Dev. & Ops. …BUY$15K–$50K3K$8.07Sep 2, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K2K$9.05Aug 30, 2022
BENTSUR RONChairman & CEOBUY$100K–$500K19K$8.69Aug 22, 2022
BENTSUR RONChairman & CEOBUY$100K–$500K20K$8.40Aug 16, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K4K$11.63Jun 30, 2022
BENTSUR RONChairman & CEOBUY$1K–$15K700$12.09Jun 27, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K1K$15.82May 31, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K1K$16.73May 23, 2022
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K300$16.54May 23, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K2K$19.48May 19, 2022
Shemesh ShayChief Dev. & Ops. …BUY$1K–$15K242$19.44May 18, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K2K$18.82May 17, 2022
Hoberman KennethDirectorBUY$100K–$500K6K$17.40May 16, 2022
Kaplan Matthew L.DirectorBUY$50K–$100K3K$16.88May 16, 2022
Poradosu EnriqueChief Science & Bu…BUY$1K–$15K670$15.33May 16, 2022
Shemesh ShayChief Dev. & Ops. …BUY$15K–$50K1K$15.85May 13, 2022
BENTSUR RONChairman & CEOBUY$100K–$500K12K$16.99May 13, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K4K$7.05Mar 29, 2022
BENTSUR RONChairman & CEOBUY$50K–$100K7K$7.63Mar 18, 2022
BENTSUR RONChairman & CEOBUY$15K–$50K8K$5.88Feb 15, 2022
BENTSUR RONChairman & CEOBUY$50K–$100K9K$6.34Feb 11, 2022
Poradosu EnriqueChief Science & Bu…BUY$15K–$50K5K$3.44Feb 8, 2022
Shemesh ShayChief Development …BUY$1K–$15K3K$3.41Feb 8, 2022
BENTSUR RONChairman & CEOBUY$1M+233K$4.96Feb 8, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 39 funds holding

FundShares
IRIDIAN ASSET MANAGEMENT LLC/CT536K
BALDWIN WEALTH PARTNERS LLC/MA390K
Occam Crest Management LP380K
GEODE CAPITAL MANAGEMENT, LLC312K
STATE STREET CORP155K
OPPENHEIMER & CO INC74K
FORBES J M & CO LLP59K
CHARLES SCHWAB INVESTMENT MANAGEMENT INC44K
BARCLAYS PLC24K
Austin Wealth Management, LLC20K
JANE STREET GROUP, LLC18K
Nuveen, LLC17K
GOLDMAN SACHS GROUP INC15K
CIBC Private Wealth Group LLC15K
Avalon Trust Co14K
NATIONS FINANCIAL GROUP INC, /IA/ /ADV13K
RHUMBLINE ADVISERS8K
UBS Group AG8K
Bank of New York Mellon Corp8K
VANGUARD GROUP INC6K

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Pontifax VI G.P. L.P.

SC 13G/A · Nov 5, 2024

1.5%

289K shares

Charles Mosseri-Marlio

SC 13G/A · Feb 28, 2024

15.0%

2.6M shares

Enrique Poradosu

SC 13G/A · Feb 1, 2024

8.7%

1.5M shares

Shay Shemesh

SC 13G/A · Feb 1, 2024

8.6%

1.5M shares

Thomas Peters

SC 13G/A · Jan 31, 2024

5.2%

908K shares

Thomas Peters

SC 13G · Apr 3, 2023

6.4%

948K shares

Shay Shemesh

SC 13G · Feb 13, 2023

8.2%

1.2M shares

Enrique Poradosu

SC 13G · Feb 13, 2023

8.3%

1.2M shares

Charles Mosseri-Marlio

SC 13G/A · Jan 9, 2023

16.3%

2.4M shares

Charles Mosseri-Marlio

SC 13G/A · Mar 28, 2022

11.0%

1.4M shares

Ron Bentsur

SC 13D · Mar 28, 2022

21.5%

2.7M shares

View on Google Finance →